Conditions: Migraine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 207
Healthy volunteers: no

Brief summary:
The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.

Detailed description:

Arms:
arm 1: Active Drug arm 2: Matching Pbo Comparator

Interventions: intervention 1: Comparator: rizatriptan benzoate intervention 2: Comparator: Placebo
Intervention descriptions: intervention 1: Rizatriptan 10 mg Orally Disintegrating Tablet (ODT); one dose, treatment of a single migraine attack intervention 2: Matching placebo; one dose, treatment of a single migraine attack

Protocol document: